Literature DB >> 29057168

Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities.

Archi Joardar1, Ernesto Manzo1, Daniela C Zarnescu1,2,3.   

Abstract

PURPOSE OF REVIEW: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease for which there is no cure and treatments are at best palliative. Several genes have been linked to ALS, which highlight defects in multiple cellular processes including RNA processing, proteostasis and metabolism. Clinical observations have identified glucose intolerance and dyslipidemia as key features of ALS however the causes of these metabolic alterations remain elusive. RECENT
FINDINGS: Recent studies reveal that motor neurons and muscle cells may undergo cell type specific metabolic changes that lead to utilization of alternate fuels. For example, ALS patients' muscles exhibit reduced glycolysis and increased reliance on fatty acids. In contrast, ALS motor neurons contain damaged mitochondria and exhibit impaired lipid beta oxidation, potentially leading to increased glycolysis as a compensatory mechanism.
SUMMARY: These findings highlight the complexities of metabolic alterations in ALS and provide new opportunities for designing therapeutic strategies based on restoring cellular energetics.

Entities:  

Keywords:  ALS; C9orf72; SOD1; TDP-43; glycolysis; lipid metabolism; mitochondria; motor neuron

Year:  2017        PMID: 29057168      PMCID: PMC5647833          DOI: 10.1007/s40142-017-0123-8

Source DB:  PubMed          Journal:  Curr Genet Med Rep        ISSN: 2167-4876


  47 in total

1.  Peripheral nerve protein glycation and muscle fructolysis: evidence of abnormal carbohydrate metabolism in ALS.

Authors:  K R Poulton; M L Rossi
Journal:  Funct Neurol       Date:  1993 Jan-Feb

2.  Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS.

Authors:  Shuying Sun; Ying Sun; Shuo-Chien Ling; Laura Ferraiuolo; Melissa McAlonis-Downes; Yiyang Zou; Kevin Drenner; Yin Wang; Dara Ditsworth; Seiya Tokunaga; Alex Kopelevich; Brian K Kaspar; Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

3.  Impaired glucose tolerance in patients with amyotrophic lateral sclerosis.

Authors:  Pierre-Francois Pradat; Gaelle Bruneteau; Paul H Gordon; Luc Dupuis; Dominique Bonnefont-Rousselot; Dominique Simon; Francois Salachas; Philippe Corcia; Vincent Frochot; Jean-Marc Lacorte; Claude Jardel; Christiane Coussieu; Nadine Le Forestier; Lucette Lacomblez; Jean-Philippe Loeffler; Vincent Meininger
Journal:  Amyotroph Lateral Scler       Date:  2010

4.  The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.

Authors:  Burkhard Schütz; Jens Reimann; Lucia Dumitrescu-Ozimek; Karin Kappes-Horn; Gary E Landreth; Britta Schürmann; Andreas Zimmer; Michael T Heneka
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

6.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.

Authors:  L Dupuis; P Corcia; A Fergani; J-L Gonzalez De Aguilar; D Bonnefont-Rousselot; R Bittar; D Seilhean; J-J Hauw; L Lacomblez; J-P Loeffler; V Meininger
Journal:  Neurology       Date:  2008-01-16       Impact factor: 9.910

7.  Hypermetabolism in ALS patients: an early and persistent phenomenon.

Authors:  C Bouteloup; J-C Desport; P Clavelou; N Guy; H Derumeaux-Burel; A Ferrier; P Couratier
Journal:  J Neurol       Date:  2009-03-22       Impact factor: 4.849

8.  Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase.

Authors:  Alexandre Henriques; Vincent Croixmarie; David A Priestman; Angela Rosenbohm; Sylvie Dirrig-Grosch; Eleonora D'Ambra; Mylene Huebecker; Ghulam Hussain; Claire Boursier-Neyret; Andoni Echaniz-Laguna; Albert C Ludolph; Frances M Platt; Bernard Walther; Michael Spedding; Jean-Philippe Loeffler; Jose-Luis Gonzalez De Aguilar
Journal:  Hum Mol Genet       Date:  2015-10-19       Impact factor: 6.150

9.  Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis.

Authors:  Gabriel N Valbuena; Milena Rizzardini; Sara Cimini; Alexandros P Siskos; Caterina Bendotti; Lavinia Cantoni; Hector C Keun
Journal:  Mol Neurobiol       Date:  2015-05-12       Impact factor: 5.590

10.  Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.

Authors:  Valentina Gallo; Petra A Wark; Mazda Jenab; Neil Pearce; Carol Brayne; Roel Vermeulen; Peter M Andersen; Goran Hallmans; Andreas Kyrozis; Nicola Vanacore; Mariam Vahdaninia; Verena Grote; Rudolf Kaaks; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Ruth C Travis; Jesper Petersson; Oskar Hansson; Larraitz Arriola; Juan-Manuel Jimenez-Martin; Anne Tjønneland; Jytte Halkjær; Claudia Agnoli; Carlotta Sacerdote; Catalina Bonet; Antonia Trichopoulou; Diana Gavrila; Kim Overvad; Elisabete Weiderpass; Domenico Palli; J Ramón Quirós; Rosario Tumino; Kay-Tee Khaw; Nicholas Wareham; Aurelio Barricante-Gurrea; Veronika Fedirko; Pietro Ferrari; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Heiner Boeing; Matthaeus Vigl; Lefkos Middleton; Elio Riboli; Paolo Vineis
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

View more
  9 in total

Review 1.  Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers.

Authors:  Francesco Liguori; Susanna Amadio; Cinzia Volonté
Journal:  Cell Mol Life Sci       Date:  2021-07-28       Impact factor: 9.261

Review 2.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

3.  Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.

Authors:  Maria Elena Cicardi; Riccardo Cristofani; Paola Rusmini; Marco Meroni; Veronica Ferrari; Giulia Vezzoli; Barbara Tedesco; Margherita Piccolella; Elio Messi; Mariarita Galbiati; Alessandra Boncoraglio; Serena Carra; Valeria Crippa; Angelo Poletti
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

4.  Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS.

Authors:  Ernesto Manzo; Ileana Lorenzini; Dianne Barrameda; Abigail G O'Conner; Jordan M Barrows; Alexander Starr; Tina Kovalik; Benjamin E Rabichow; Erik M Lehmkuhl; Dakotah D Shreiner; Archi Joardar; Jean-Charles Liévens; Robert Bowser; Rita Sattler; Daniela C Zarnescu
Journal:  Elife       Date:  2019-06-10       Impact factor: 8.140

Review 5.  The links between diabetes mellitus and amyotrophic lateral sclerosis.

Authors:  Rosario Vasta; Fabrizio D'Ovidio; Giancarlo Logroscino; Adriano Chiò
Journal:  Neurol Sci       Date:  2021-02-05       Impact factor: 3.307

6.  Overlapping Genetic Architecture Between Schizophrenia and Neurodegenerative Disorders.

Authors:  Chunyu Li; Tianmi Yang; Ruwei Ou; Huifang Shang
Journal:  Front Cell Dev Biol       Date:  2021-12-24

7.  Apolipoprotein A1 Enhances Endothelial Cell Survival in an In Vitro Model of ALS.

Authors:  Svitlana Garbuzova-Davis; Alison E Willing; Cesario V Borlongan
Journal:  eNeuro       Date:  2022-07-28

8.  Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis.

Authors:  Débora Lanznaster; Clément Bruno; Jérôme Bourgeais; Patrick Emond; Ilyess Zemmoura; Antoine Lefèvre; Pascal Reynier; Sébastien Eymieux; Emmanuelle Blanchard; Patrick Vourc'h; Christian R Andres; Salah Eddine Bakkouche; Olivier Herault; Luc Favard; Philippe Corcia; Hélène Blasco
Journal:  Biomedicines       Date:  2022-06-02

Review 9.  Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis.

Authors:  Emanuele D'Amico; Giuseppe Grosso; Jeri W Nieves; Aurora Zanghì; Pam Factor-Litvak; Hiroshi Mitsumoto
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.